Sudha Biddinger, M.D.,Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Lipogenesis | 9 | 2021 | 214 | 1.610 |
Why?
|
| Receptor, Insulin | 15 | 2022 | 836 | 1.590 |
Why?
|
| Liver | 25 | 2022 | 7512 | 1.420 |
Why?
|
| Insulin | 21 | 2022 | 6593 | 1.340 |
Why?
|
| Insulin Resistance | 16 | 2021 | 3954 | 1.140 |
Why?
|
| Cholesterol | 7 | 2020 | 2903 | 1.020 |
Why?
|
| Hypercholesterolemia | 5 | 2022 | 1141 | 0.990 |
Why?
|
| Gluconeogenesis | 6 | 2018 | 185 | 0.900 |
Why?
|
| Methylamines | 2 | 2019 | 136 | 0.770 |
Why?
|
| Sterol Regulatory Element Binding Protein 1 | 4 | 2022 | 135 | 0.760 |
Why?
|
| Serine Endopeptidases | 2 | 2016 | 1022 | 0.700 |
Why?
|
| Leptin | 7 | 2018 | 1595 | 0.690 |
Why?
|
| Oxygenases | 2 | 2019 | 59 | 0.660 |
Why?
|
| Gene Expression Regulation | 9 | 2017 | 11874 | 0.660 |
Why?
|
| Hyperlipidemias | 2 | 2022 | 770 | 0.640 |
Why?
|
| eIF-2 Kinase | 1 | 2019 | 145 | 0.640 |
Why?
|
| Dyslipidemias | 3 | 2019 | 868 | 0.620 |
Why?
|
| Fructose | 2 | 2017 | 288 | 0.600 |
Why?
|
| Lipodystrophy | 2 | 2016 | 145 | 0.600 |
Why?
|
| Hepatocytes | 6 | 2017 | 1231 | 0.590 |
Why?
|
| Mice, Obese | 6 | 2019 | 418 | 0.590 |
Why?
|
| Triglycerides | 9 | 2021 | 2459 | 0.550 |
Why?
|
| Sterol Regulatory Element Binding Protein 2 | 2 | 2014 | 56 | 0.540 |
Why?
|
| Orphan Nuclear Receptors | 2 | 2015 | 63 | 0.520 |
Why?
|
| Diabetes Mellitus, Type 1 | 2 | 2022 | 3415 | 0.520 |
Why?
|
| Obesity | 8 | 2020 | 12933 | 0.510 |
Why?
|
| Stearoyl-CoA Desaturase | 2 | 2006 | 85 | 0.500 |
Why?
|
| Proprotein Convertases | 1 | 2016 | 95 | 0.490 |
Why?
|
| Forkhead Transcription Factors | 4 | 2015 | 1614 | 0.480 |
Why?
|
| Diabetes Mellitus, Type 2 | 11 | 2020 | 12142 | 0.470 |
Why?
|
| Mice, Knockout | 19 | 2019 | 14389 | 0.470 |
Why?
|
| Lovastatin | 1 | 2014 | 115 | 0.440 |
Why?
|
| Hepatitis | 1 | 2015 | 228 | 0.440 |
Why?
|
| Nephrotic Syndrome | 1 | 2016 | 390 | 0.400 |
Why?
|
| Glucose | 5 | 2018 | 4345 | 0.390 |
Why?
|
| Apolipoproteins B | 1 | 2013 | 385 | 0.380 |
Why?
|
| Mice | 34 | 2023 | 81368 | 0.350 |
Why?
|
| Mice, Inbred C57BL | 13 | 2023 | 22115 | 0.330 |
Why?
|
| Diet, Fat-Restricted | 2 | 2017 | 329 | 0.320 |
Why?
|
| Phosphoproteins | 1 | 2017 | 2446 | 0.310 |
Why?
|
| Atherosclerosis | 3 | 2019 | 3400 | 0.310 |
Why?
|
| Animals | 39 | 2023 | 168201 | 0.310 |
Why?
|
| Hep G2 Cells | 2 | 2019 | 378 | 0.290 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2017 | 2895 | 0.280 |
Why?
|
| Cholelithiasis | 1 | 2008 | 407 | 0.270 |
Why?
|
| Gene Knockdown Techniques | 4 | 2015 | 1608 | 0.270 |
Why?
|
| Bile Acids and Salts | 3 | 2022 | 393 | 0.260 |
Why?
|
| Insulin-Like Growth Factor Binding Protein 1 | 1 | 2005 | 127 | 0.240 |
Why?
|
| RNA, Messenger | 5 | 2015 | 12758 | 0.240 |
Why?
|
| Blood Glucose | 11 | 2019 | 6390 | 0.230 |
Why?
|
| Insulin-Like Growth Factor I | 2 | 2018 | 1932 | 0.230 |
Why?
|
| Cholesterol, LDL | 3 | 2022 | 2379 | 0.230 |
Why?
|
| CCAAT-Enhancer-Binding Proteins | 1 | 2005 | 286 | 0.220 |
Why?
|
| Dietary Fats | 4 | 2013 | 1995 | 0.220 |
Why?
|
| Insulin-Like Growth Factor Binding Protein 3 | 1 | 2005 | 416 | 0.220 |
Why?
|
| Glycemic Index | 1 | 2005 | 396 | 0.210 |
Why?
|
| Receptors, Leptin | 3 | 2018 | 350 | 0.210 |
Why?
|
| Steroid 12-alpha-Hydroxylase | 1 | 2022 | 9 | 0.200 |
Why?
|
| Gene Expression | 4 | 2018 | 7568 | 0.200 |
Why?
|
| Apolipoprotein C-III | 2 | 2016 | 210 | 0.200 |
Why?
|
| Mice, Transgenic | 5 | 2018 | 9529 | 0.190 |
Why?
|
| Sitosterols | 1 | 2020 | 8 | 0.180 |
Why?
|
| Phytosterols | 1 | 2020 | 55 | 0.180 |
Why?
|
| Signal Transduction | 11 | 2018 | 23416 | 0.180 |
Why?
|
| Simvastatin | 1 | 2022 | 346 | 0.170 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2014 | 3244 | 0.160 |
Why?
|
| Phosphoenolpyruvate Carboxykinase (GTP) | 1 | 2017 | 40 | 0.150 |
Why?
|
| Glucose-6-Phosphatase | 1 | 2017 | 72 | 0.150 |
Why?
|
| Blotting, Western | 2 | 2016 | 5034 | 0.150 |
Why?
|
| Transcription Factors | 5 | 2017 | 12116 | 0.150 |
Why?
|
| MicroRNAs | 3 | 2019 | 3805 | 0.140 |
Why?
|
| Lipids | 3 | 2018 | 3332 | 0.140 |
Why?
|
| Fatty Acids | 2 | 2018 | 1808 | 0.130 |
Why?
|
| Lipoproteins | 3 | 2008 | 879 | 0.130 |
Why?
|
| Crosses, Genetic | 2 | 2015 | 750 | 0.130 |
Why?
|
| Aspartic Acid Endopeptidases | 1 | 2018 | 311 | 0.130 |
Why?
|
| Transcriptional Activation | 2 | 2014 | 1755 | 0.130 |
Why?
|
| Oligonucleotides | 1 | 2019 | 566 | 0.130 |
Why?
|
| Pyruvate Kinase | 1 | 2018 | 189 | 0.130 |
Why?
|
| Jejunum | 1 | 2018 | 472 | 0.130 |
Why?
|
| Mice, 129 Strain | 2 | 2014 | 370 | 0.130 |
Why?
|
| Cardiovascular Diseases | 2 | 2019 | 15498 | 0.130 |
Why?
|
| Biosynthetic Pathways | 2 | 2014 | 135 | 0.130 |
Why?
|
| HEK293 Cells | 3 | 2019 | 4269 | 0.130 |
Why?
|
| Cross-Over Studies | 1 | 2022 | 2079 | 0.130 |
Why?
|
| Gallstones | 1 | 2008 | 284 | 0.130 |
Why?
|
| Metabolic Diseases | 1 | 2022 | 680 | 0.120 |
Why?
|
| Fatty Liver | 2 | 2012 | 787 | 0.120 |
Why?
|
| DNA-Binding Proteins | 3 | 2011 | 9586 | 0.120 |
Why?
|
| Thyroid Hormones | 1 | 2018 | 403 | 0.120 |
Why?
|
| Anthropometry | 1 | 2019 | 1338 | 0.120 |
Why?
|
| Energy Intake | 2 | 2017 | 2132 | 0.120 |
Why?
|
| Half-Life | 1 | 2015 | 650 | 0.110 |
Why?
|
| Mass Spectrometry | 2 | 2019 | 2189 | 0.110 |
Why?
|
| Carcinoma, Hepatocellular | 2 | 2017 | 2291 | 0.110 |
Why?
|
| Amyloid Precursor Protein Secretases | 1 | 2018 | 620 | 0.110 |
Why?
|
| Cholesterol, Dietary | 2 | 2008 | 224 | 0.110 |
Why?
|
| Oxidation-Reduction | 2 | 2018 | 2231 | 0.110 |
Why?
|
| Rats | 5 | 2019 | 23717 | 0.110 |
Why?
|
| Male | 20 | 2019 | 360358 | 0.110 |
Why?
|
| Aortic Aneurysm, Abdominal | 1 | 2023 | 1228 | 0.110 |
Why?
|
| Hyperglycemia | 2 | 2015 | 1375 | 0.110 |
Why?
|
| Random Allocation | 1 | 2017 | 2392 | 0.110 |
Why?
|
| Humans | 27 | 2023 | 760617 | 0.110 |
Why?
|
| Young Adult | 6 | 2020 | 59179 | 0.100 |
Why?
|
| Azetidines | 1 | 2014 | 142 | 0.100 |
Why?
|
| Receptors, LDL | 1 | 2015 | 488 | 0.100 |
Why?
|
| Fasting | 3 | 2014 | 1603 | 0.100 |
Why?
|
| Lipoproteins, VLDL | 1 | 2013 | 201 | 0.100 |
Why?
|
| Podocytes | 1 | 2016 | 405 | 0.100 |
Why?
|
| Phospholipids | 1 | 2015 | 786 | 0.100 |
Why?
|
| Diabetes Mellitus, Experimental | 2 | 2015 | 1117 | 0.090 |
Why?
|
| Indoles | 1 | 2019 | 1830 | 0.090 |
Why?
|
| Ketones | 1 | 2012 | 183 | 0.090 |
Why?
|
| Protein Kinase C-delta | 1 | 2011 | 114 | 0.090 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2015 | 1169 | 0.090 |
Why?
|
| Models, Animal | 3 | 2014 | 2109 | 0.090 |
Why?
|
| ATP-Binding Cassette Transporters | 2 | 2008 | 563 | 0.090 |
Why?
|
| Metagenome | 1 | 2013 | 448 | 0.090 |
Why?
|
| Acyl-CoA Dehydrogenase, Long-Chain | 1 | 2010 | 49 | 0.090 |
Why?
|
| Hypothalamic Hormones | 1 | 2010 | 145 | 0.080 |
Why?
|
| Pituitary Hormones | 1 | 2010 | 182 | 0.080 |
Why?
|
| Sirtuin 3 | 1 | 2010 | 67 | 0.080 |
Why?
|
| Gastric Bypass | 1 | 2018 | 818 | 0.080 |
Why?
|
| Liver Diseases | 2 | 2008 | 1297 | 0.080 |
Why?
|
| Choline | 2 | 2023 | 515 | 0.080 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2016 | 3800 | 0.080 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2016 | 4570 | 0.080 |
Why?
|
| Melanins | 1 | 2010 | 289 | 0.080 |
Why?
|
| Cholesterol, HDL | 1 | 2015 | 1810 | 0.080 |
Why?
|
| Membrane Proteins | 2 | 2018 | 7847 | 0.080 |
Why?
|
| Steroid Hydroxylases | 1 | 2008 | 93 | 0.080 |
Why?
|
| Gastrointestinal Tract | 1 | 2013 | 833 | 0.070 |
Why?
|
| Antigens, CD | 1 | 2018 | 3998 | 0.070 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 2 | 2010 | 858 | 0.070 |
Why?
|
| Dietary Carbohydrates | 1 | 2012 | 891 | 0.070 |
Why?
|
| Phospholipid Transfer Proteins | 1 | 2008 | 90 | 0.070 |
Why?
|
| Body Weight | 3 | 2010 | 4614 | 0.070 |
Why?
|
| Adolescent | 4 | 2020 | 88234 | 0.070 |
Why?
|
| Rats, Zucker | 2 | 2019 | 131 | 0.070 |
Why?
|
| Recombinant Proteins | 1 | 2016 | 6520 | 0.070 |
Why?
|
| RNA Interference | 2 | 2012 | 2830 | 0.070 |
Why?
|
| Carrier Proteins | 2 | 2018 | 4935 | 0.070 |
Why?
|
| Sex Characteristics | 1 | 2017 | 2637 | 0.070 |
Why?
|
| Receptors, Estrogen | 1 | 2014 | 2208 | 0.070 |
Why?
|
| Cell Cycle Proteins | 1 | 2017 | 3447 | 0.070 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2014 | 2456 | 0.060 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2014 | 3777 | 0.060 |
Why?
|
| Hypothalamus | 1 | 2010 | 999 | 0.060 |
Why?
|
| Female | 13 | 2019 | 392148 | 0.060 |
Why?
|
| Case-Control Studies | 2 | 2020 | 22148 | 0.060 |
Why?
|
| Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 2 | 2022 | 318 | 0.060 |
Why?
|
| Hypertriglyceridemia | 1 | 2008 | 293 | 0.060 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2015 | 8166 | 0.060 |
Why?
|
| Diabetes Complications | 1 | 2010 | 1315 | 0.060 |
Why?
|
| Cell Line | 2 | 2015 | 15576 | 0.050 |
Why?
|
| Cell Nucleus | 1 | 2012 | 2894 | 0.050 |
Why?
|
| Bacteria | 1 | 2013 | 2192 | 0.050 |
Why?
|
| Body Mass Index | 1 | 2020 | 12943 | 0.050 |
Why?
|
| Mice, Inbred Strains | 1 | 2005 | 1759 | 0.050 |
Why?
|
| Hypoglycemic Agents | 1 | 2015 | 3085 | 0.050 |
Why?
|
| Gene Deletion | 2 | 2022 | 2661 | 0.050 |
Why?
|
| Base Sequence | 2 | 2019 | 12421 | 0.050 |
Why?
|
| Sex Factors | 1 | 2016 | 10548 | 0.050 |
Why?
|
| DNA Primers | 1 | 2006 | 2817 | 0.050 |
Why?
|
| Liver Neoplasms | 1 | 2017 | 4308 | 0.050 |
Why?
|
| Child | 3 | 2019 | 80079 | 0.050 |
Why?
|
| Gene Expression Profiling | 2 | 2015 | 9417 | 0.050 |
Why?
|
| Disease Susceptibility | 1 | 2008 | 1788 | 0.050 |
Why?
|
| Polymerase Chain Reaction | 2 | 2007 | 6074 | 0.040 |
Why?
|
| Homeostasis | 1 | 2011 | 3321 | 0.040 |
Why?
|
| Adult | 6 | 2020 | 220969 | 0.040 |
Why?
|
| Cells, Cultured | 2 | 2012 | 18937 | 0.040 |
Why?
|
| Diet, Atherogenic | 1 | 2019 | 92 | 0.040 |
Why?
|
| Cross-Sectional Studies | 2 | 2017 | 26049 | 0.040 |
Why?
|
| Up-Regulation | 3 | 2014 | 4117 | 0.040 |
Why?
|
| Neoplasms | 2 | 2018 | 22131 | 0.040 |
Why?
|
| Receptors, Cell Surface | 1 | 2007 | 2802 | 0.040 |
Why?
|
| Cohort Studies | 2 | 2019 | 41457 | 0.040 |
Why?
|
| Diabetes Mellitus | 2 | 2018 | 5835 | 0.040 |
Why?
|
| Mitochondria | 1 | 2010 | 3619 | 0.030 |
Why?
|
| Glucose Tolerance Test | 2 | 2010 | 1178 | 0.030 |
Why?
|
| Gene Knockout Techniques | 1 | 2019 | 801 | 0.030 |
Why?
|
| Diet | 1 | 2013 | 8048 | 0.030 |
Why?
|
| Risk Factors | 2 | 2019 | 74115 | 0.030 |
Why?
|
| Glycosylation | 1 | 2018 | 1098 | 0.030 |
Why?
|
| Bilophila | 1 | 2013 | 12 | 0.030 |
Why?
|
| Hepatocyte Nuclear Factor 3-beta | 1 | 2014 | 63 | 0.030 |
Why?
|
| Food Microbiology | 1 | 2013 | 74 | 0.030 |
Why?
|
| Fermentation | 1 | 2013 | 142 | 0.030 |
Why?
|
| Bacteroides | 1 | 2013 | 165 | 0.030 |
Why?
|
| Swine | 1 | 2023 | 5907 | 0.030 |
Why?
|
| Child, Preschool | 1 | 2016 | 42188 | 0.030 |
Why?
|
| Disease Models, Animal | 3 | 2019 | 18221 | 0.030 |
Why?
|
| Macaca mulatta | 1 | 2019 | 2328 | 0.030 |
Why?
|
| Diet, Vegetarian | 1 | 2013 | 180 | 0.020 |
Why?
|
| Phosphorylation | 2 | 2014 | 8311 | 0.020 |
Why?
|
| Thiazolidinediones | 1 | 2014 | 460 | 0.020 |
Why?
|
| Enzyme Induction | 1 | 2011 | 452 | 0.020 |
Why?
|
| Hepatocyte Nuclear Factor 4 | 1 | 2010 | 126 | 0.020 |
Why?
|
| NF-kappa B | 1 | 2019 | 2481 | 0.020 |
Why?
|
| Hydrolysis | 1 | 2011 | 661 | 0.020 |
Why?
|
| Down-Regulation | 1 | 2017 | 2915 | 0.020 |
Why?
|
| Counseling | 1 | 2017 | 1538 | 0.020 |
Why?
|
| Carnitine | 1 | 2010 | 252 | 0.020 |
Why?
|
| Body Temperature Regulation | 1 | 2010 | 292 | 0.020 |
Why?
|
| Time Factors | 3 | 2017 | 39913 | 0.020 |
Why?
|
| Lentivirus | 1 | 2010 | 507 | 0.020 |
Why?
|
| Gene Expression Regulation, Bacterial | 1 | 2013 | 1131 | 0.020 |
Why?
|
| Glucose Clamp Technique | 1 | 2008 | 262 | 0.020 |
Why?
|
| Caloric Restriction | 1 | 2010 | 299 | 0.020 |
Why?
|
| Acetylation | 1 | 2010 | 1055 | 0.020 |
Why?
|
| Thinness | 1 | 2010 | 480 | 0.020 |
Why?
|
| Feces | 1 | 2013 | 1490 | 0.020 |
Why?
|
| Glucose Intolerance | 1 | 2011 | 575 | 0.020 |
Why?
|
| Toll-Like Receptor 4 | 1 | 2010 | 578 | 0.020 |
Why?
|
| Species Specificity | 1 | 2011 | 2411 | 0.020 |
Why?
|
| Heat-Shock Proteins | 1 | 2010 | 795 | 0.020 |
Why?
|
| Suppressor of Cytokine Signaling Proteins | 1 | 2007 | 178 | 0.020 |
Why?
|
| Fatty Acids, Nonesterified | 1 | 2008 | 393 | 0.020 |
Why?
|
| Mice, Inbred NOD | 1 | 2010 | 1827 | 0.020 |
Why?
|
| Cold Temperature | 1 | 2010 | 784 | 0.020 |
Why?
|
| Weight Loss | 1 | 2017 | 2682 | 0.020 |
Why?
|
| Neuroglia | 1 | 2010 | 955 | 0.010 |
Why?
|
| Adipose Tissue, Brown | 1 | 2010 | 762 | 0.010 |
Why?
|
| Boston | 1 | 2017 | 9313 | 0.010 |
Why?
|
| Eating | 1 | 2010 | 1535 | 0.010 |
Why?
|
| Adenosine Triphosphate | 1 | 2010 | 1988 | 0.010 |
Why?
|
| Transfection | 1 | 2010 | 5766 | 0.010 |
Why?
|
| Hypoglycemia | 1 | 2010 | 883 | 0.010 |
Why?
|
| Protein Isoforms | 1 | 2007 | 1697 | 0.010 |
Why?
|
| Analysis of Variance | 1 | 2010 | 6224 | 0.010 |
Why?
|
| Lipid Metabolism | 1 | 2010 | 1896 | 0.010 |
Why?
|
| Models, Biological | 1 | 2008 | 9461 | 0.010 |
Why?
|
| RNA-Binding Proteins | 1 | 2010 | 1890 | 0.010 |
Why?
|
| Genetic Vectors | 1 | 2010 | 3392 | 0.010 |
Why?
|
| Adiposity | 1 | 2010 | 1879 | 0.010 |
Why?
|
| Cell Culture Techniques | 1 | 2008 | 1662 | 0.010 |
Why?
|
| Age Factors | 1 | 2017 | 18381 | 0.010 |
Why?
|
| Promoter Regions, Genetic | 1 | 2010 | 5780 | 0.010 |
Why?
|
| Inflammatory Bowel Diseases | 1 | 2013 | 2423 | 0.010 |
Why?
|
| Adipose Tissue | 1 | 2010 | 3309 | 0.010 |
Why?
|
| Immunity, Innate | 1 | 2010 | 3045 | 0.010 |
Why?
|
| Cell Line, Tumor | 1 | 2014 | 16967 | 0.010 |
Why?
|
| Energy Metabolism | 1 | 2008 | 2878 | 0.010 |
Why?
|
| Middle Aged | 3 | 2018 | 220584 | 0.010 |
Why?
|
| Aging | 1 | 2011 | 8699 | 0.010 |
Why?
|
| Neurons | 1 | 2010 | 9438 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2017 | 64568 | 0.010 |
Why?
|
| Mutation | 1 | 2011 | 30016 | 0.000 |
Why?
|